Genotyping of Plasmodium Vivax by Minisatellite Marker and Its Application in Differentiating Relapse and New Infection

Overview

Journal Malar J

Publisher Biomed Central

Specialty Tropical Medicine

Date 2016 Feb 26

PMID 26912225

Citations 3

Authors

Ram Das

Ramesh C Dhiman

Deepali Savargaonkar

Anupkumar R Anvikar

Neena Valecha

Affiliations

Soon will be listed here.

Abstract

Background: Plasmodium vivax malaria is a major public health problem in India. Control of vivax malaria is challenging due to various factors including relapse which increase the burden significantly. There is no well studied marker to differentiate relapse from reinfection. This creates hindrance in search for anti-relapse medicines. The genomic study of minisatellite can help in characterization of relapse and new infection of vivax malaria.

Methods: Eighty-eight samples of P. vivax were collected from malaria clinic. All the 14 chromosomes of P. vivax were scanned for minisatellite marker by Tandem Repeat Finder software Version 4.07b. Minisatellite marker CH1T1M13779 from chromosome one was applied for genotyping in 88 samples of P. vivax including 2 recurrence cases.

Results: Whole genome of P. vivax was scanned and found to have one hundred minisatellite markers. CH1T1M13779 minisatellite marker from chromosome-1 was used for amplification in 88 samples of P. vivax. Of 66 amplified samples, 14 alleles were found with varied allele frequency. The base size of 280 (13.63 %) 320 bp (13.63 %) and 300 bp (16.66 %) showed the predominant allele in the P. vivax population. Genotyping of two paired samples (day 0 and day relapse) could demonstrate the presence of relapse and reinfection.

Conclusion: The CH1T1M13779 can be potential minisatellite marker which can be used to differentiate between relapse and new infection of P. vivax strain.

Citing Articles

Genetic diversity of the MSP-3α gene in isolates circulating in the National Capital Region (NCR) of India.

Das R, Vashisht K, Savargaonkar D, Mercy Aparna L, Nayak A, Pandey K Parasite Epidemiol Control. 2024; 26:e00362.

PMID: 38975253 PMC: 11225027. DOI: 10.1016/j.parepi.2024.e00362.

Analysis of the relapse of imported Plasmodium vivax and Plasmodium ovale in five provinces of China.

Yan H, Wei S, Sui Y, Lu S, Zhang W, Feng X Malar J. 2023; 22(1):209.

PMID: 37443070 PMC: 10347707. DOI: 10.1186/s12936-023-04642-y.

Epidemiology of Plasmodium vivax Malaria in Peru.

Rosas-Aguirre A, Gamboa D, Manrique P, Conn J, Moreno M, Lescano A Am J Trop Med Hyg. 2016; 95(6 Suppl):133-144.

PMID: 27799639 PMC: 5201219. DOI: 10.4269/ajtmh.16-0268.

References

Adak T, Valecha N, Sharma V . Plasmodium vivax polymorphism in a clinical drug trial. Clin Diagn Lab Immunol. 2001; 8(5):891-4. PMC: 96166. DOI: 10.1128/CDLI.8.5.891-894.2001. View

Lin J, Hathaway N, Saunders D, Lon C, Balasubramanian S, Kharabora O . Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse. J Infect Dis. 2015; 212(6):999-1008. PMC: 4548463. DOI: 10.1093/infdis/jiv142. View

Han E, Park J, Shin E, Choi M, Oh M, Chai J . Apical membrane antigen-1 (AMA-1) gene sequences of re-emerging Plasmodium vivax in South Korea. Korean J Parasitol. 2002; 40(3):157-62. PMC: 2721043. DOI: 10.3347/kjp.2002.40.3.157. View

Putaporntip C, Jongwutiwes S, Sakihama N, Ferreira M, Kho W, Kaneko A . Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Proc Natl Acad Sci U S A. 2002; 99(25):16348-53. PMC: 138614. DOI: 10.1073/pnas.252348999. View

Cui L, Escalante A, Imwong M, Snounou G . The genetic diversity of Plasmodium vivax populations. Trends Parasitol. 2003; 19(5):220-6. DOI: 10.1016/s1471-4922(03)00085-0. View

Hay S, Guerra C, Tatem A, Noor A, Snow R . The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis. 2004; 4(6):327-36. PMC: 3145123. DOI: 10.1016/S1473-3099(04)01043-6. View

Rayner J, Huber C, Feldman D, Ingravallo P, Galinski M, Barnwell J . Plasmodium vivax merozoite surface protein PvMSP-3 beta is radically polymorphic through mutation and large insertions and deletions. Infect Genet Evol. 2004; 4(4):309-19. DOI: 10.1016/j.meegid.2004.03.003. View

Benson G . Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res. 1998; 27(2):573-80. PMC: 148217. DOI: 10.1093/nar/27.2.573. View

Imwong M, Pukrittayakamee S, Gruner A, Renia L, Letourneur F, Looareesuwan S . Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malar J. 2005; 4:20. PMC: 1131918. DOI: 10.1186/1475-2875-4-20. View

10.

Sousa T, Ceravolo I, Fontes C, Couto A, Carvalho L, Brito C . The pattern of major polymorphisms in the Duffy binding protein ligand domain among Plasmodium vivax isolates from the Brazilian Amazon area. Mol Biochem Parasitol. 2005; 146(2):251-4. DOI: 10.1016/j.molbiopara.2005.11.006. View

11.

Kim J, Imwong M, Nandy A, Chotivanich K, Nontprasert A, Tonomsing N . Genetic diversity of Plasmodium vivax in Kolkata, India. Malar J. 2006; 5:71. PMC: 1560144. DOI: 10.1186/1475-2875-5-71. View

12.

Zakeri S, Barjesteh H, Djadid N . Merozoite surface protein-3alpha is a reliable marker for population genetic analysis of Plasmodium vivax. Malar J. 2006; 5:53. PMC: 1579225. DOI: 10.1186/1475-2875-5-53. View

13.

Prajapati S, Verma A, Adak T, Yadav R, Kumar A, Eapen A . Allelic dimorphism of Plasmodium vivax gam-1 in the Indian subcontinent. Malar J. 2006; 5:90. PMC: 1630701. DOI: 10.1186/1475-2875-5-90. View

14.

Gomez A, Suarez C, Martinez P, Saravia C, Patarroyo M . High polymorphism in Plasmodium vivax merozoite surface protein-5 (MSP5). Parasitology. 2006; 133(Pt 6):661-72. DOI: 10.1017/S0031182006001168. View

15.

Yang Z, Miao J, Huang Y, Li X, Putaporntip C, Jongwutiwes S . Genetic structures of geographically distinct Plasmodium vivax populations assessed by PCR/RFLP analysis of the merozoite surface protein 3beta gene. Acta Trop. 2006; 100(3):205-12. PMC: 1839953. DOI: 10.1016/j.actatropica.2006.10.011. View

16.

Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim J, Nandy A . Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis. 2007; 195(7):927-33. DOI: 10.1086/512241. View

17.

Koepfli C, Mueller I, Marfurt J, Goroti M, Sie A, Oa O . Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials. J Infect Dis. 2009; 199(7):1074-80. DOI: 10.1086/597303. View

18.

Prajapati S, Joshi H, Valecha N . Plasmodium vivax merozoite surface protein-3 alpha: a high-resolution marker for genetic diversity studies. J Vector Borne Dis. 2010; 47(2):85-90. View

19.

White N . Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011; 10:297. PMC: 3228849. DOI: 10.1186/1475-2875-10-297. View

20.

Prajapati S, Joshi H, Shalini S, Patarroyo M, Suwanarusk R, Kumar A . Plasmodium vivax lineages: geographical distribution, tandem repeat polymorphism, and phylogenetic relationship. Malar J. 2011; 10:374. PMC: 3258263. DOI: 10.1186/1475-2875-10-374. View